Peptide COA results near the limit: uncertainty and acceptance rules

Read the reported result together with its uncertainty, units and measurement basis. An uncertainty statement describes the dispersion associated with the measured quantity. It does not establish the identity of the peptide, the suitability of a cosmetic formulation or the representativeness of an entire shipment. A laboratory result remains tied to the material and method identified in its report.

NIST expresses expanded uncertainty as U = k × uc, where uc is combined standard uncertainty and k is a coverage factor. When a normal distribution applies and uc reliably estimates the standard deviation, k = 2 gives approximately 95% coverage. That qualification matters: a bare “±” sign leaves the interpretation incomplete. For a peptide powder purchase, ask whether the uncertainty applies to water content, peptide assay or another specific measurand. Request clarification before using the number in an acceptance calculation.

A result can meet a numerical specification limit while missing a stricter acceptance limit. ILAC G8 distinguishes simple acceptance from rules using a guard band. For an upper limit, a guard band moves the acceptance boundary below the specification boundary. The agreed rule determines the conformity statement.

Consider a hypothetical water-content specification of no more than 2.00% by mass. Suppose the result is 1.90%, with expanded uncertainty of 0.20 percentage points. Simple acceptance would accept this result. If the agreed rule instead requires result plus U to remain at or below 2.00%, the acceptance boundary is 1.80%; the result misses it. The arithmetic is 1.90 + 0.20 = 2.10%. These invented values illustrate a purchasing decision. They are not a recommended moisture limit, a Hytanbio test result or a claim that the material's true water content equals 2.10%.

Write down the acceptance calculation before a sample is tested. ILAC G8 calls for decision rules to be agreed and documented before the work starts, and identified in the conformity report unless inherent in the specification. It also recognizes that different rules can produce different conclusions for the same result.

For a cosmetic peptide sourcing project, a practical purchase record should identify the material code, batch, property, method and reporting basis beside the limit. Then state who makes the acceptance decision and which calculation they use. Keep this record attached to the approved specification revision. A buyer reviewing a later shipment should be able to recover the original rule without searching through informal messages. If the supplier and receiving laboratory use different methods, resolve comparability before interpreting a difference as a batch failure. The checklist below is an editorial purchasing aid, not a prescribed contractual template.

Place the disposition decision with the responsible quality team and retain both reports. Start by checking whether the tests describe the same batch, sample condition, property and reporting basis. A result on a dry basis cannot be compared directly with an as-received result without a justified conversion. HPLC area purity also answers a different question from peptide content by mass.

For the investigation record, request the laboratory's explanation of the uncertainty statement and the rule behind any pass or fail wording. Document why additional testing is needed, how the sample will be selected and how the new result will be evaluated. Do not choose whichever result makes the shipment acceptable. An uncertainty interval crossing a limit does not, by itself, settle the purchase decision. The agreed rule and investigation findings determine the next action. This review concerns ingredient acceptance; finished-product safety and suitability need their own assessment.